TearLab: Here’s What Investors Need to Know Before Earnings

TearLab (NASDAQ:TEAR) will report earnings after markets close on Monday, May 13th. TearLab Corp. is an in-vitro diagnostics company. The Company develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears at the point-of-care.

Here is your Cheat Sheet to Tearlab Earnings:

Earnings Expectations: Analysts expect earnings of $-0.12 per share on revenues of $2.18 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.09 to a loss $0.12. For the current year, the average estimate is a loss of $0.43, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Tearlab has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 0.46 0.87 1.70 2.12 3.96
Diluted EPS ($) -2.29 -0.44 -0.47 -0.50 -0.76

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 0.50 0.42 0.72 1.21 1.61
Diluted EPS ($) -0.1699 -0.44 -0.10 -0.17 -0.1276

Past Performance:
Tearlab has beat analyst estimates 1 time in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)